Home › Cervical Cancer › NCT06416150
Reducing Urban Cervical Cancer Disparities
Reducing Urban Cervical Cancer Disparities Using a Tailored MHealth Intervention to Enhance Colposcopy Attendance
Who can join
Ages 18 to 90 · Women · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * 18 to 90 years of age (screening is still recommended for some women over 65-depending on screening and medical history and proceeds until age 90 in the study's clinic recruitment sites), * referral for colposcopic evaluation at the clinic sites, * able to communicate with ease in English, * have a cell phone with texting ability, and * competent to give consent. Exclusion Criteria: * are pregnant at the time of recruitment, * display current evidence or have a history of positive invasive carcinoma of the cervix, or * require follow-up but not a colposcopy.
About the study
This study uses a hybrid Type 1 effectiveness-implementation trial to operationalize and assess the efficacy of the Health Enhancement Resource System (HERS) intervention. HERS aims to increase patient follow-up after abnormal test results through text message-based barriers counseling for women and supplemental telephone-based Health Coaching for women who miss their appointment.
What is being tested
- Stage 1 SOC (behavioral)
- Stage 1 HERS (behavioral)
- Stage 2 HERS (behavioral)
- Stage 2 HERS+HC (behavioral)
- Stage 3 SOC (behavioral)
- Stage 3 HERS (behavioral)
Sponsor: Fox Chase Cancer Center · Participants: 546 · Started: Aug 28, 2024
Contact the study team
- Suzanne M Miller, PhD · Phone: 215-728-4069
- Erin K Tagai, PhD, MPH · Phone: 215-728-5621
Official record on ClinicalTrials.gov — NCT06416150
Locations in the U.S.
| New Jersey | Rutgers, The State University of New Jersey, New Brunswick |
| Pennsylvania | Fox Chase Cancer Center, Philadelphia Thomas Jefferson University, Philadelphia |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.